Birmingham, West Midlands -- (SBWIRE) -- 01/22/2014 -- Value Penny Stocks issues special report on Kandi Technologies Group Inc (NASDAQ:KNDI), PDL BioPharma Inc. (NASDAQ:PDLI), Bridgeline Digital Inc (NASDAQ:BLIN), Pluristem Therapeutics Inc. (NASDAQ:PSTI).
Kandi Technologies Group Inc (NASDAQ:KNDI) ended its recent business day with the loss of -3.13% and closed at the price of $13.33 after opening at $14.17. The stock traded during its last trading session with the total volume of 2,103,950 shares, as compared to its average volume of 2.89 million shares. Kandi Technologies Group, Inc., through its subsidiaries, engages in the design, development, manufacture, and commercialization of various vehicles. It offers electrical vehicles, all-terrain vehicles, go-karts, and specialized automobiles; and utility vehicles, three-wheeled motorcycle, refitted cars, super-mini-cars, and various auto generators.
Has KNDI Found The Bottom and Ready To Move Up? Find Out Here
PDL BioPharma Inc. (NASDAQ:PDLI) remained among the day advancers and traded with volume of 2,057,292 shares in the last session, as compared to average volume of 2.30 million shares. In comparison with 52 week range of $6.50 - $10.20, it faced lowest price of $9.01 during the last trading session whereas its day highest price was $9.22. The company’s total market capitalization is $1.28 billion, along with 140.05 million shares outstanding. PDL BioPharma, Inc. engages in intellectual property asset management and patent portfolio and related assets investment activities. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases, as well as other medical conditions.
Why Should Investors Buy PDLI After The Recent Gain? Just Go Here and Find Out
Bridgeline Digital Inc (NASDAQ:BLIN) showed 2,056,631 shares in volume during the last trading session, while the average trading volume remained 87,850.00 shares. The stock kicked off its trading session at $1.20 and closed at $1.44 after mounting 21.33%. Bridgeline Digital, Inc. develops iAPPS Web engagement management product platform and related digital solutions in the United States. Its iAPPS platform enables companies and developers to create Websites, Web applications, and online stores.
For How Long BLIN will Fight for Profitability? Read This Trend Analysis report
Pluristem Therapeutics Inc. (NASDAQ:PSTI) stock traded during its last trading session with the total traded volume of 2,047,126 shares versus its average volume of 404,491.00 shares. The company opened its trade at the price of $4.61 and its closing price was $4.17 after losing -5.87% for the day. Pluristem Therapeutics Inc., through its subsidiary, Pluristem Ltd., operates as a bio-therapeutics company. It is engaged in the research, development, and commercialization of standardized cell therapy products and related technologies for the treatment of local and systemic diseases.
Will PSTI Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)